Ultragenyx Pharmaceutical Inc.
RARE | NASDAQ
$15.74
+$1.09 (+7.44%)
Sep 22, 2026, 2:41 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -92M | -185M | -128.56M | -180.41M | -114.95M | -151.08M | -133.39M | -133.52M | -131.6M | -170.68M | -123.19M | -159.65M | -159.83M | -163.97M | -151.83M | -245.11M | -158.16M | -152.32M | -122.46M | -73M | -122.43M | -136.14M |
Depreciation & Amortization | 8M | 8M | 8.79M | 8.61M | -11.77M | 8.99M | 9.08M | 8.76M | 8.86M | 8.85M | 8.22M | 7.19M | 5.36M | 5.24M | 4.96M | 4.69M | 4.48M | 4.09M | 3.53M | 3.22M | 3.12M | 3.37M |
Stock-Based Compensation | 34M | 30M | 37.29M | 37.01M | 38.53M | 39.92M | 40.16M | 41.57M | 39.37M | 36.93M | n/a | 34.88M | 34.65M | 31.95M | 29.36M | 35.76M | 35.86M | 29.4M | 26.82M | 26.79M | 27.09M | 24.25M |
Other Working Capital | 12M | -9M | -2.74M | 9.91M | 313K | -17.48M | 45.85M | 23.54M | -7M | 6.55M | -1.26M | 4.99M | 12.11M | -519K | 122K | 5.87M | 40.08M | 5.92M | -31.17M | -9.7M | -7.45M | -52.14M |
Other Non-Cash Items | -18M | 1M | -17.94M | -11.49M | 1.73M | -7.67M | -18.11M | -14.63M | -9.96M | -9.8M | 17.76M | -1.83M | -3.51M | 8.28M | 5.33M | 87.14M | 12.65M | 13M | -1.14M | -19.76M | 36.63M | 26.43M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.62M | -1.26M | n/a | n/a | n/a | n/a | n/a | n/a | 18.21M | n/a | n/a | n/a |
Change in Working Capital | -29M | -51M | 588K | 54.86M | -21.81M | -56.63M | 22.75M | 30.83M | 16.36M | -56.02M | 14.92M | 2.8M | 7.16M | -38.36M | 21.85M | 22.17M | 27.91M | -11.69M | 20.69M | 3.1M | -9.77M | -77.26M |
Operating Cash Flow | -97M | -197M | -99.83M | -91.42M | -108.27M | -166.48M | -79.5M | -67M | -76.96M | -190.73M | -83.9M | -117.87M | -116.16M | -156.87M | -90.34M | -95.35M | -77.26M | -117.52M | -54.34M | -59.65M | -65.36M | -159.35M |
Capital Expenditures | -1M | -1M | -938K | -1.28M | 12.54M | -16.32M | -654K | -1.62M | -4.51M | -13.21M | -1.6M | -3.7M | -16.44M | -25.03M | -26.97M | -26.05M | -30.92M | -62.18M | -16.05M | -20.56M | -20.07M | -16.41M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 366K | n/a | n/a | n/a | 79.84M | n/a | n/a | n/a |
Purchase of Investments | -57M | -131M | -153.56M | -16.94M | -15.5M | n/a | -15.93M | -367.38M | -3.37M | -21.93M | -221.59M | -139.48M | -103.28M | -62.02M | -198.57M | -210.88M | -1.57M | -206.17M | -94.78M | -253.06M | -259.12M | -405.23M |
Sales Maturities Of Investments | 105M | 88M | 81.97M | 135.59M | 89.45M | 136.99M | 119.45M | 93.7M | 68.49M | 131.64M | 116.45M | 207.9M | 219.54M | 202.31M | 54.18M | 150.64M | 111.84M | 228.41M | 180.34M | 233.35M | 237.94M | 239.22M |
Other Investing Acitivies | -3M | -5M | 273K | -185K | -308K | -15.78M | -127K | -203K | -2.54M | -12.07M | -271K | -428K | -2.9M | -3.95M | -604K | -75.57M | -183K | 2.58M | -80.3M | -487K | n/a | n/a |
Investing Cash Flow | 44M | -49M | -72.25M | 117.18M | 71.18M | 119.89M | 102.74M | -275.5M | 60.56M | 94.44M | -107.02M | 64.3M | 99.42M | 111.3M | -171.6M | -161.86M | 79.17M | -37.36M | 69.06M | -40.76M | -41.25M | -182.42M |
Debt Repayment | n/a | n/a | 392M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a | 157K | 3.19M | 11.06M | 384.94M | -58K | 4.15M | 442K | 33.02M | -722K | 1.88M | 491.88M | 5.84M | -143K | 6.78M | 7.55M | 12.63M | 12.65M |
Financial Cash Flow | 3M | n/a | 394.19M | 2K | 83.65M | 157K | 3.19M | 11.17M | 384.94M | -58K | 330.61M | 25.23M | 33.02M | -722K | 1.88M | 491.88M | 5.84M | 1.61M | 85.73M | 7.55M | 12.63M | 12.65M |
Net Cash Flow | -49M | -251M | 221.66M | 26.06M | 49.47M | -44.98M | 23.95M | -330.05M | 367.89M | -97.03M | 140.79M | -29.06M | 16.14M | -46.07M | -258.71M | 233.59M | 6.51M | -153.38M | 100.05M | -93.34M | -93.53M | -329.89M |
Free Cash Flow | -98M | -198M | -100.77M | -92.7M | -95.73M | -182.8M | -80.16M | -68.61M | -81.47M | -203.94M | -85.5M | -121.57M | -132.6M | -181.9M | -117.31M | -121.39M | -108.18M | -179.71M | -70.39M | -80.21M | -85.43M | -175.76M |
Adj. Free Cash Flow | -132M | -228M | -138.06M | -129.71M | -134.26M | -222.72M | -120.32M | -110.18M | -120.84M | -240.86M | -85.5M | -156.45M | -167.25M | -213.85M | -146.67M | -157.15M | -144.04M | -209.1M | -97.21M | -107M | -112.52M | -200.01M |
Maintenance CapEx | -1M | -1M | n/a | n/a | 22.77M | -325.11K | n/a | n/a | n/a | -8.52M | n/a | n/a | -4.93M | -12.56M | -15.04M | -20.63M | -29.51M | -62.18M | -16.05M | -20.46M | -6.11M | n/a |
Growth CapEx | n/a | n/a | -938K | -1.28M | -10.23M | -16M | -654K | -1.62M | -4.51M | -4.69M | -1.6M | -3.7M | -11.5M | -12.47M | -11.93M | -5.41M | -1.42M | n/a | n/a | -97.8K | -13.96M | -16.41M |
Owner Earnings | -98M | -198M | -99.83M | -91.42M | -85.51M | -166.8M | -79.5M | -67M | -76.96M | -199.25M | -83.9M | -117.87M | -121.09M | -169.43M | -105.38M | -115.98M | -106.76M | -179.71M | -70.39M | -80.11M | -71.47M | -159.35M |
Add to Watchlist
Select watchlists to add or remove RARE